BIOL - BiolaseAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $0.28 | Open | $0.29 |
| Volume | 782.1K | Market Cap | 25.17M |
| Yield | Last Dividend |
| BIOLASE Hosts Nearly 400 Dental Professi... | 09/15/20 |
| FOOTHILL RANCH, Calif., Sept. 15, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it hoste... | |
| Global Dental Lasers Market: COVID-19 Bu... | 09/15/20 |
| LONDON--(BUSINESS WIRE)-- #DentalLasersMarket--The Global Dental Lasers Market will grow by $ 190.10 mn during 2020-2024 | |
| BIOLASE to Highlight Progress and Recent... | 09/03/20 |
| FOOTHILL RANCH, Calif., Sept. 3, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norb... | |
| BIOLASE Reports Second Quarter 2020 Fina... | 08/13/20 |
| FOOTHILL RANCH, Calif., Aug. 13, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial ... | |
| BIOLASE Announces Closing Of Oversubscri... | 07/22/20 |
| IRVINE, Calif., July 22, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, further strengthened its balance sheet t... | |
| BIOLASE Announces Expiration Of Oversubs... | 07/16/20 |
| IRVINE, Calif., July 16, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, announced today the expiration of the Co... | |
| BIOLASE to Present at COVID-19 Webinar H... | 07/09/20 |
| IRVINE, Calif., July 9, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that BIOLASE CEO Todd N... | |
| BIOLASE's Epic Hygiene Laser Meets Guide... | 07/08/20 |
| IRVINE, Calif., July 8, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the Epic Hygiene d... | |
| BIOL to raise its stake in Bupa Arabia | 06/10/20 |
| Riyadh ??? Mubasher: Bupa Investments Overseas Limited (BIOL) is planning to increase its shareholding in Bupa Arabia from 39.25% to 43.25%. The compa... | |
| BIOLASE Reports First Quarter 2020 Finan... | 05/07/20 |
| IRVINE, Calif., May 7, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results fo... | |
| BIOLASE, Inc to Report First Quarter 202... | 04/30/20 |
| IRVINE, Calif., April 30, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release ... | |
| The Daily Biotech Pulse: Sanofi, Regener... | 04/07/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 6.) F... | |
| The Daily Biotech Pulse: Fate Therapeuti... | 04/03/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 2) BEL... | |
| The Daily Biotech Pulse: InflaRx Begins ... | 04/01/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 31) At... | |
| The Daily Biotech Pulse: Pfizer's Eczema... | 03/19/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18)... | |
| BIOLASE Announces Clearance of the Epic ... | 12/09/19 |
| IRVINE, Calif., Dec. 9, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced the launch of their new Epic ... | |
| BIOLASE Announces Schedule Of Investor C... | 11/26/19 |
| IRVINE, Calif., Nov. 26, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to... | |
| BIOLASE Appoints Michael DiTolla, DDS, F... | 11/15/19 |
| IRVINE, Calif., Nov. 15, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it appointed Michael D... | |
| BIOLASE : Reports Third Quarter 2019 Res... | 11/06/19 |
| BIOLASE Reports Third Quarter 2019 Results Download as PDFNovember 06, 2019 4:05pm EST Related Documents Audio ??? | November 6, 2019 | |
| The Daily Biotech Pulse: FDA Approves Cl... | 10/09/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. None of the NYSE or Nasdaq-listed biotech stocks hit 52-we... | |
| Biolase's (BIOL) CEO Todd Norbe on Q1 20... | 05/11/19 |
| No summary available. | |
| Biolase misses by $0.03, misses on reven... | 05/09/19 |
| No summary available. | |
| BIOLASE, Inc. (BIOL) CEO Todd Norbe on Q... | 03/05/19 |
| No summary available. | |
| Biolase beats by $0.05, beats on revenue | 03/05/19 |
| No summary available. | |
| Mallinckrodt and Aerie Pharmaceuticals a... | 02/26/19 |
| No summary available. | |
| BIOLASE up 26% | 02/13/19 |
| No summary available. | |
| Biolase up 4% on cross-promotion deal wi... | 01/29/19 |
| No summary available. | |
| Date | 2020-08-13 (AMC) | Est. (EPS/Rev.) | ($0.17)/ 2.09M |
| Actual (EPS/Rev.) | $-0.12/ $2.94 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Arbitrage Trade Analytics | Royce Wells | 71.00 % | Subscribe |
| Swing Trading Cheap Stocks <~ $10 | Michael S. DeVries | 65.00 % | Follow |
| Tracking ONLY-VOLBAND DAILY BREAK- | Jay | 36.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
